VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.633
EU - Europa 1.293
AS - Asia 1.013
SA - Sud America 232
AF - Africa 15
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.192
Nazione #
US - Stati Uniti d'America 2.554
SG - Singapore 466
IE - Irlanda 412
UA - Ucraina 287
BR - Brasile 204
CN - Cina 191
HK - Hong Kong 147
GB - Regno Unito 138
DE - Germania 109
IT - Italia 105
IN - India 61
CA - Canada 59
SE - Svezia 51
FI - Finlandia 48
CH - Svizzera 43
BD - Bangladesh 28
TR - Turchia 28
FR - Francia 19
BE - Belgio 18
ES - Italia 16
JP - Giappone 14
IL - Israele 12
MX - Messico 12
VN - Vietnam 12
NL - Olanda 9
IR - Iran 8
PL - Polonia 8
IQ - Iraq 7
PK - Pakistan 7
RU - Federazione Russa 7
AR - Argentina 6
EC - Ecuador 6
EE - Estonia 6
CO - Colombia 5
AU - Australia 4
CL - Cile 4
ID - Indonesia 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
KR - Corea 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PY - Paraguay 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.192
Città #
Dallas 473
Dublin 412
Chandler 263
Jacksonville 252
Singapore 244
San Jose 185
Hong Kong 145
Ashburn 120
Boardman 112
London 112
The Dalles 101
Chicago 100
Beijing 90
Santa Clara 68
Wilmington 68
Helsinki 48
Dearborn 46
Toronto 43
Zurich 43
San Mateo 29
Capo D'orlando 27
Princeton 27
Istanbul 20
São Paulo 20
Ann Arbor 19
Brussels 18
Columbus 17
Los Angeles 17
Falls Church 16
Leawood 16
Padova 14
Tokyo 12
Council Bluffs 11
Frankfurt am Main 11
Azor 10
Catania 10
Hefei 10
New Orleans 10
New York 10
Augusta 9
Brooklyn 9
Kunming 9
Milan 9
Norwalk 9
Chennai 8
Edinburgh 8
Hillsboro 8
Monmouth Junction 8
Munich 8
Madrid 7
Orem 7
Pune 7
Warsaw 7
Belo Horizonte 6
Düsseldorf 6
Naples 6
Rio de Janeiro 6
Tallinn 6
Atlanta 5
Manchester 5
Messina 5
Mexico City 5
Porto Alegre 5
Rome 5
San Francisco 5
Amsterdam 4
Assago 4
Boston 4
Des Moines 4
Ho Chi Minh City 4
Kyiv 4
Mumbai 4
Nanchang 4
Quito 4
Seattle 4
Tashkent 4
Ardabil 3
Bangalore 3
Campinas 3
Charlotte 3
Goiânia 3
Guangzhou 3
Gunzenhausen 3
Hanoi 3
Jaipur 3
Jakarta 3
Johannesburg 3
Joinville 3
Lauterbourg 3
Montreal 3
Nanjing 3
Osasco 3
Piscataway 3
Reston 3
Seoul 3
Wuhan 3
Antakya 2
Aracaju 2
Atibaia 2
Basra 2
Totale 3.539
Nome #
The p53-homologue p63may promote thyroid cancer progression 164
p53 family proteins in thyroid cancer 155
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 151
TAp63α antagonizes p53 oncosuppressor function in thyroid cancer cells 150
p73 Tumor-Suppressor Activity is Impaired in Human thyroid Cancer 146
Metabolic alterations of thyroid cancer as potential therapeutic targets 137
BRAF(V600E) mutation and the biology of papillary thyroid cancer 135
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 121
Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics 120
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 114
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid 114
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 112
Immunostaining for MET/HCF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 111
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease 110
P73 tumor-suppressor activity is impaired in human thyroid cancer 107
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 102
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 100
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 99
Levels of histone acetylation in thyroid tumors. 98
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 97
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? 94
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 93
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 90
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 89
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis 89
The IGF system in thyroid cancer:new concepts 88
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 88
TAp73 Increases tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 86
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 85
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 85
Il BRAF(V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al Gefitinib 82
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 79
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 78
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 75
miRNA upregulation in thyroid cancer is caused by the inhibition of the p53 pathway 74
COVID-19 and Diabetes: The Importance of Controlling RAGE 73
Identification of Thyroid Cancer Stem Cells 73
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 73
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 70
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 68
Genome wide analysis in papillary thyroid carcinoma 68
Insulin Receptor Isoforms in Physiology and Disease: An Updated View 68
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 62
The expression of PTEN tumor suppressor is down regulated by dominant negative p73 isoform ΔNp73 in thyroid cancer cells 61
Editorial: Early diagnoses and treatments of uncommon breast cancers 60
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 56
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 55
Regulation of miRNAs by p53 family members in thyroid cancer cells 53
Reactivation of p53 mutants by small compounds may represent an adjuvant therapy of poorly differentiated thyroid cancer 52
Thyrospheres an in vitro model for human thyroid carcinogenesis 51
Role of Braf (v600) mutation in the resistance to Gefitinib of thyroid cancer cells. 50
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 50
Isolation of thyroid cancer stem cells 48
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 35
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 34
null 33
null 29
null 29
null 27
null 26
null 25
null 25
null 25
null 25
null 24
null 24
null 23
null 22
null 22
null 21
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway. 7
Totale 5.265
Categoria #
all - tutte 32.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 0 0 4 69 9 25 3 59 21 27 15 35
2022/2023854 62 19 29 121 128 108 14 104 122 26 99 22
2023/2024634 40 76 46 27 71 24 86 26 23 24 119 72
2024/2025963 37 56 83 34 122 87 130 48 94 101 117 54
2025/20261.603 88 343 234 151 65 90 189 135 116 109 42 41
2026/202725 25 0 0 0 0 0 0 0 0 0 0 0
Totale 5.265